keyword
MENU ▼
Read by QxMD icon Read
search

Eurocare

keyword
https://www.readbyqxmd.com/read/29056464/a-population-based-comparison-of-european-and-north-american-sinonasal-cancer-survival
#1
Aykut A Unsal, Suat Kılıç, Pariket M Dubal, Soly Baredes, Jean Anderson Eloy
OBJECTIVE: Sinonasal cancers (SNC) are rare, thus limiting previous prognostic studies on a multinational level. The aim of this study is to utilize two population-based datasets to compare prognoses for SNC between the United States (US) and Europe. METHODS: The European Cancer Registry (EUROCARE) database and the United States National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) database were searched to identify survival of patients diagnosed with SNC between 1990 and 2007...
October 19, 2017: Auris, Nasus, Larynx
https://www.readbyqxmd.com/read/29032924/epidemiology-of-rare-cancers-and-inequalities-in-oncologic-outcomes
#2
G Gatta, A Trama, R Capocaccia
Rare cancers epidemiology is better known compared to the other rare diseases. Thanks to the long history of the European population-based cancer registries and to the EUROCARE huge database, the burden of rare cancers has been estimated the European (EU28) population. A considerable fraction of all cancers is represented by rare cancers (24%). They are a heterogeneous group of diseases, but they share similar problems: uncertainty of diagnosis, lack of therapies, poor research opportunities, difficulties in clinical trials, lack of expertise and of centres of reference...
September 19, 2017: European Journal of Surgical Oncology
https://www.readbyqxmd.com/read/28865261/quality-analysis-of-population-based-information-on-cancer-stage-at-diagnosis-across-europe-with-presentation-of-stage-specific-cancer-survival-estimates-a%C3%A2-eurocare-5-study
#3
MULTICENTER STUDY
Pamela Minicozzi, Kaire Innos, Maria-José Sánchez, Annalisa Trama, Paul M Walsh, Rafael Marcos-Gragera, Nadya Dimitrova, Laura Botta, Otto Visser, Silvia Rossi, Andrea Tavilla, Milena Sant
BACKGROUND: Cancer registries (CRs) are fundamental for estimating cancer burden, evaluating screening and monitoring health service performance. Stage at diagnosis-an essential information item collected by CRs-has been made available, for the first time, by CRs participating in EUROCARE-5. We analysed the quality of this information and estimated stage-specific survival across Europe for CRs with good data quality. DATA AND METHODS: Sixty-two CRs sent stage (as TNM, condensed TNM or extent of disease) for 15 cancers diagnosed in 2000-2007...
October 2017: European Journal of Cancer
https://www.readbyqxmd.com/read/28718071/cancer-survival-in-adult-patients-in-spain-results-from-nine-population-based-cancer-registries
#4
M D Chirlaque, D Salmerón, J Galceran, A Ameijide, A Mateos, A Torrella, R Jiménez, N Larrañaga, R Marcos-Gragera, E Ardanaz, M Sant, P Minicozzi, C Navarro, M J Sánchez
INTRODUCTION: With the aim of providing cancer control indicators, this work presents cancer survival in adult (≥15 years) patients in Spain diagnosed during the period 2000-2007 from Spanish cancer registries participating in the EUROCARE project. METHODS: Cancer cases from nine Spanish population-based cancer registries were included and analysed as a whole. All primary malignant neoplasms diagnosed in adult patients were eligible for the analysis. Cancer patients were followed until 31 December 2008...
July 17, 2017: Clinical & Translational Oncology
https://www.readbyqxmd.com/read/28689091/geographical-variability-in-survival-of-european-children-with-central-nervous-system-tumours
#5
G Gatta, R Peris-Bonet, O Visser, C Stiller, R Marcos-Gragera, M-J Sánchez, B Lacour, P Kaatsch, F Berrino, S Rutkowski, L Botta
Survival for childhood central nervous system (CNS) tumours varies across Europe, partly because of the difficulty of distinguishing malignant from non-malignant disease. This study examines bias in CNS tumours survival analysis to obtain the reliable and comparable survival figures. We analysed survival data for about 15,000 children (age <15) diagnosed with CNS between 2000 and 2007, from 71 population-based cancer registries in 27 countries. We selected high-quality data based on registry-specific data quality indicators and recorded observed 1-year and 5-year survival by countries and CNS entity...
September 2017: European Journal of Cancer
https://www.readbyqxmd.com/read/28558920/corrigendum-to-exercise-based-cardiac-rehabilitation-in-twelve-european-countries-results-of-the-european-cardiac-rehabilitation-registry-int-j-cardiol-228-2017-58-67
#6
Werner Benzer, Bernhard Rauch, Jean-Paul Schmid, Ann Dorthe Zwisler, Paul Dendale, Constantinos H Davos, Evangelia Kouidi, Attila Simon, Ana Abreu, Nana Pogosova, Dan Gaita, Bojan Miletic, Gerd Bönner, Taoufik Ouarrak, Hannah McGee
No abstract text is available yet for this article.
September 1, 2017: International Journal of Cardiology
https://www.readbyqxmd.com/read/28474265/gene-expression-signatures-for-head-and-neck-cancer-patient-stratification-are-results-ready-for-clinical-application
#7
REVIEW
Luca Tonella, Marco Giannoccaro, Salvatore Alfieri, Silvana Canevari, Loris De Cecco
Head and neck squamous cell carcinoma (HNSCC) is the sixth leading cancer by incidence worldwide and considering the recent EUROCARE-5 population-based study the 5-year survival rate of HNSCC patients in Europe ranges between 69% in localized cases and 34% in patients with regional involvement. The development of high-throughput gene expression assays in the last two decades has provided the invaluable opportunity to improve our knowledge on cancer biology and to identify predictive signatures in the most deeply analyzed malignancies, such as hematological and breast cancers...
May 2017: Current Treatment Options in Oncology
https://www.readbyqxmd.com/read/28410490/survival-of-86-690-patients-with-thyroid-cancer-a-population-based-study-in-29-european-countries-from-eurocare-5
#8
MULTICENTER STUDY
L Dal Maso, A Tavilla, F Pacini, D Serraino, B A C van Dijk, M D Chirlaque, R Capocaccia, N Larrañaga, M Colonna, D Agius, E Ardanaz, J Rubió-Casadevall, A Kowalska, S Virdone, S Mallone, H Amash, R De Angelis
BACKGROUND: Incidence rates of thyroid cancer (TC) increased in several countries during the last 30 years, while mortality rates remained unchanged, raising important questions for treatment and follow-up of TC patients. This study updates population-based estimates of relative survival (RS) after TC diagnosis in Europe by sex, country, age, period and histology. METHODS: Data from 87 cancer registries in 29 countries were extracted from the EUROCARE-5 dataset...
May 2017: European Journal of Cancer
https://www.readbyqxmd.com/read/28005615/trends-in-net-survival-from-kidney-cancer-in-six-european-latin-countries-results-from-the-sudcan-population-based-study
#9
Lucia Mangone, Nadine Bossard, Rafael Marcos-Gragera, Annamaria Pezzarossi, Francesca Roncaglia, Paolo Giorgi Rossi
Kidney cancer is a frequent malignant disease. To date, there is no evidence on the effectiveness of early detection and, in most cases, surgery represents the only standard treatment. So far, there is no standardized therapy for localized and locally advanced renal tumors; however, the recent introduction of target therapy has significantly improved the prognosis of metastatic disease. Therefore, survival differences in Europe are deemed to involve differences in diagnostic and therapeutic approaches. The aim of the SUDCAN collaborative study was to compare the net survival from kidney cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis...
January 2017: European Journal of Cancer Prevention
https://www.readbyqxmd.com/read/28005614/trends-in-net-survival-from-prostate-cancer-in-six-european-latin-countries-results-from-the-sudcan-population-based-study
#10
Pascale Grosclaude, Laurent Roche, Rafael Fuentes-Raspall, Nerea Larrañaga
Cancer survival is a key measure of the effectiveness of a health-care system. European Latin countries have some differences in their health system; therefore, it is of interest to compare them in terms of survival from cancer. Prostate cancer data from six countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) were extracted from the EUROCARE-5 database (end of follow-up: 1 January 2009). First, the net survival (NS) was studied over the 2000-2004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country...
January 2017: European Journal of Cancer Prevention
https://www.readbyqxmd.com/read/28005613/trends-in-net-survival-from-ovarian-cancer-in-six-european-latin-countries-results-from-the-sudcan-population-based-study
#11
María-Dolores Chirlaque, Zoé Uhry, Diego Salmerón, María-Isabel Sánchez-Zapata, Gian Franco Zannoni, Carmen Navarro
European Latin countries have some similarities in their health systems. It is thus interesting to look at their differences in cancer survival (here, ovarian cancer) through monitoring of specific indicators of quality care. The aim of this SUDCAN collaborative study was to compare the trends in 1 and 5-year net survival from ovarian cancer and the trends in the excess mortality rates between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland). The data were extracted from the EUROCARE-5 database...
January 2017: European Journal of Cancer Prevention
https://www.readbyqxmd.com/read/28005612/trends-in-net-survival-from-corpus-uteri-cancer-in-six-european-latin-countries-results-from-the-sudcan-population-based-study
#12
Luís Antunes, Laurent Roche, Maria José Bento
Corpus uteri cancer is the most common gynaecological cancer in women in Europe, but presents a relatively good prognosis. There were two main objectives in this study: estimate differences between countries in age-standardized net survival (NS) at 1 and 5 years in 2000-2004 and evaluate time trends in NS and excess mortality rates in 1992-2004. Data on corpus uteri malignant tumours (International Classification of Diseases for Oncology, third ed.: C54) were extracted from the EUROCARE database for six European Latin countries: Belgium, France, Italy, Portugal, Spain and Switzerland...
January 2017: European Journal of Cancer Prevention
https://www.readbyqxmd.com/read/28005611/trends-in-net-survival-from-cervical-cancer-in-six-european-latin-countries-results-from-the-sudcan-population-based-study
#13
Annemie Haelens, Laurent Roche, Joana Bastos, Anne-Sophie Woronoff, Manuel Zorzi, Julie Francart
Cancer survival is a key measure of the effectiveness of a healthcare system. As differences in healthcare systems are present among European Latin countries, it is of interest to look specifically at their similarities and differences in terms of cancer survival. Incident cases were extracted from the EUROCARE-V database for France, Italy, Spain, Switzerland, Portugal, and Belgium. One and 5-year net survivals (NS) were calculated for the period 2000-2004 using the Pohar-Perme estimator. Trends in NS over the 1992-2004 period and changes in the pattern of cancer excess mortality rate until 5 years after diagnosis were examined using a multivariate excess mortality rate model...
January 2017: European Journal of Cancer Prevention
https://www.readbyqxmd.com/read/28005610/trends-in-net-survival-from-breast-cancer-in-six-european-latin-countries-results-from-the-sudcan-population-based-study
#14
Emanuele Crocetti, Laurent Roche, Carlotta Buzzoni, Francesco di Costanzo, Florence Molinié, Adele Caldarella
Survival from breast cancer (BC) is influenced by the timeliness of diagnosis and appropriateness of treatment, and may constitute a measure of the global effectiveness of a healthcare system. As the healthcare systems of several European Latin countries have some similarities, the search for differences in cancer survival may provide interesting information on the efficacy of these systems. The SUDCAN study is a collaboration between the Group for Epidemiology and Cancer Registration in Latin language countries (GRELL) and EUROCARE...
January 2017: European Journal of Cancer Prevention
https://www.readbyqxmd.com/read/28005609/trends-in-net-survival-from-skin-malignant-melanoma-in-six-european-latin-countries-results-from-the-sudcan-population-based-study
#15
Jaume Galceran, Zoé Uhry, Rafael Marcos-Gragera, Joan Borràs
In Europe as a whole, survival from skin malignant melanoma (SMM) has increased constantly since the 1980s. The aim of the SUDCAN collaborative study was to compare the trends in the 5-year net survival from SMM and in related excess mortality rate between six European Latin countries (Belgium, France, Italy, Portugal, Spain, and Switzerland). The data were extracted from the EUROCARE-5 database (end of follow-up: 01 January 2009). First, the net survival was studied over the 2000-2004 period using the Pohar-Perme estimator...
January 2017: European Journal of Cancer Prevention
https://www.readbyqxmd.com/read/28005608/trends-in-net-survival-lung-cancer-in-six-european-latin-countries-results-from-the-sudcan-population-based-study
#16
Andrea Bordoni, Zoé Uhry, Luis Antunes
Survival is a key measure of the effectiveness of a healthcare system. European Latin countries have some similarities in their health systems; it is thus interesting to examine their differences in survival from cancer, here, lung cancer. The aim of the SUDCAN collaborative study was to compare the trends in the 1- and 5-year net survival from lung cancer and the trends in the excess mortality rates between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland). The data were extracted from the EUROCARE-5 database...
January 2017: European Journal of Cancer Prevention
https://www.readbyqxmd.com/read/28005607/trends-in-net-survival-from-pancreatic-cancer-in-six-european-latin-countries-results-from-the-sudcan-population-based-study
#17
Anne-Marie Bouvier, Nadine Bossard, Marc Colonna, Adelaida Garcia-Velasco, Maria Carulla, Sylvain Manfredi
Pancreatic cancer represents a real clinical challenge. The aim of the SUDCAN collaborative study was to compare the net survival from pancreatic cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland) and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country...
January 2017: European Journal of Cancer Prevention
https://www.readbyqxmd.com/read/28005606/trends-in-net-survival-from-liver-cancer-in-six-european-latin-countries-results-from-the-sudcan-population-based-study
#18
Stefano Ferretti, Nadine Bossard, Florence Binder-Fouchard, Jean Faivre, Andrea Bordoni, Patrizia Biavati, Antonio Frassoldati
Liver cancer represents a major clinical challenge. The aim of the SUDCAN collaborative study was to compare the net survival from liver cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain and Switzerland) and provide trends in net survival and dynamics of excess mortality rates (EMRs) up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country...
January 2017: European Journal of Cancer Prevention
https://www.readbyqxmd.com/read/28005605/trends-in-net-survival-from-rectal-cancer-in-six-european-latin-countries-results-from-the-sudcan-population-based-study
#19
Côme Lepage, Nadine Bossard, Olivier Dejardin, Maria C Carmona-Garcia, Sylvain Manfredi, Jean Faivre
Rectal cancer is a common and serious disease. The aim of the SUDCAN collaborative study was to compare the net survival from rectal cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) and provide trends in net survival and dynamics of excess mortality rates up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the period 2000-2004 using the Pohar-Perme estimator. For trend analyses, the study-period was specific to each country...
January 2017: European Journal of Cancer Prevention
https://www.readbyqxmd.com/read/28005604/trends-in-net-survival-from-colon-cancer-in-six-european-latin-countries-results-from-the-sudcan-population-based-study
#20
Jean Faivre, Nadine Bossard, Valérie Jooste
Colon cancer represents a major public health issue. The aim of the SUDCAN collaborative study was to compare the net survival from colon cancer between six European Latin countries (Belgium, France, Italy, Portugal, Spain, and Switzerland) and provide trends in net survival and dynamics of the excess mortality rates up to 5 years after diagnosis. The data were extracted from the EUROCARE-5 database. First, net survival was studied over the 2000-2004 period using the Pohar-Perme estimator. For trend analyses, the study period was specific to each country...
January 2017: European Journal of Cancer Prevention
keyword
keyword
121040
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"